Twist Bioscience Corporation TWST Reportable Segment — Litigation settlement costs, net of recoveries
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:LitigationSettlementExpense.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's reportable segment — litigation settlement costs, net of recoveries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Twist Bioscience Corporation's reportable segment — litigation settlement costs, net of recoveries?
- Twist Bioscience Corporation (TWST) reported reportable segment — litigation settlement costs, net of recoveries of $7.21M in Q1 2026.
- What does reportable segment — litigation settlement costs, net of recoveries mean?
- Reflects the net financial impact of legal disputes, settlements, or recoveries specifically associated with the reportable segment. This metric highlights potential legal risks and the financial volatility associated with the segment's regulatory or competitive environment.